PharmacoEconomics

Lessons from Trial-Based Cost-Effectiveness Analyses of Mental Health Interventions: Why Uncertainty About the Outcome, Estimate and Willingness to Pay Matters
pp. 807-816(10)
Authors: Hoch, Jeffrey S.; Dewa, Carolyn S.

Valuing Children's Health: A Comparison of Cost-Utility Analyses for Adult and Paediatric Health Interventions in the US
pp. 817-828(12)
Authors: Ladapo, Joseph A.; Neumann, Peter J.; Keren, Ron; Prosser, Lisa A.

A Comparison of the Cost Effectiveness of Pharmacotherapy or Surgery (Laparoscopic Fundoplication) in the Treatment of GORD
pp. 829-841(13)
Authors: Bojke, Laura; Hornby, Edward; Sculpher, Mark

Use of Bayesian Net Benefit Regression Model to Examine the Impact of Generic Drug Entry on the Cost Effectiveness of Selective Serotonin Reuptake Inhibitors in Elderly Depressed Patients
pp. 843-862(20)
Authors: Ya-Chen Tina Shih,; Bekele, Nebiyou B.; Xu, Ying

Cost Effectiveness of Pegaptanib for the Treatment of Age-Related Macular Degeneration in the UK
pp. 863-879(17)
Authors: Wolowacz, Sorrel E.; Roskell, Neil; Kelly, Steven; Maciver, Fiona M.; Brand, Chris S.

Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections of Insulin: Economic Comparison in Adult and Adolescent Type 1 Diabetes Mellitus in Australia
pp. 881-897(17)
Authors: Cohen, Neale; Minshall, Michael E.; Sharon-Nash, Lyn; Zakrzewska, Katerina; Valentine, William J.; Palmer, Andrew J.